Media Hub

01
Feb 2017

NHS staff still fear ‘finger of blame’ when not reporting mistakes

A report by the Public Administration and Constitutional Affairs Committee has warned that despite repeated attempts by government ministers to improve care and create more honesty within the NHS, staff are still not reporting mistakes because they fear the ‘finger of blame’. The measures, which included appointing whistleblowing guardians at all hospitals, were brought in…

Read More

01
Feb 2017

Congenital virus more common than thought in children with cerebral palsy

Research undertaken by the University of Sydney has shown that the congenital cytomegalovirus (CMV) infection in children with cerebral palsy is more common that was previously thought. The common herpes virus can cross the placenta, which carries a high risk of infecting the foetus and damaging the developing brain. The study, involving 323 children in…

Read More

25
Jan 2017

Biggest leap in prostate cancer testing ‘in decades’

Campaigners and doctors have hailed new MRI scanning equipment as a ‘huge leap’ in prostate cancer testing, and have said that using the advanced system nearly doubles the number of aggressive tumours that are caught. The trial, published in the Lancet medical journal, involved 576 men and showed that over 25 per cent could be…

Read More

19
Jan 2017

‘Dangerous’ NHS treatment delays caused by referral centres

Doctors have warned that patients are facing ‘dangerous’ delays in NHS treatment due to a huge increase in referral management centres. The centres, which were introduced in 2003, were brought about in an attempt to reduce unnecessary hospital referrals and reduce NHS spending, and in the last decade, there has been a 10-fold increase in…

Read More

19
Jan 2017

Sepsis winter health warnings

Patients are being urged to be on the look-out for the warning signs of sepsis this winter amid concerns that a lack of education could lead to people staying away from surgeries, mistaking their symptoms for flu or a common cold. In Wales alone, around 1,800 people die each year from sepsis, with one of…

Read More

19
Jan 2017

Life-extending breast cancer drug set to be withdrawn from NHS

The life-extending drug, Kadcyla, has been rejected by NICE for NHS use in England, believing that the price is too expensive. In clinical trials, Kadcyla, which costs an average of £90,000 per patient, was found to extend terminal breast cancer patients’ lives by around six months, and also dramatically improves the patient’s quality of life…

Read More